No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Scientists have made significant advances in treating Alzheimer’s, with monoclonal antibodies emerging as a major stride to stop progression and address symptoms. Alzheimer’s disease is caused by the ...

Introduction Therapeutic antibodies are laboratory-engineered proteins designed to replicate the immune system's natural ability to combat dise ...

Monoclonal antibodies are used to treat numerous health conditions ... Some disorders are associated with a deficiency, but not from a specific IgG. For example, primary immunodeficiency disease (PID) ...

Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 First Quarter Conference Call. My name is Clint ...

The potential of monoclonal antibodies (mAbs ... which could be a game changer. Here are a few examples on how companies are using AI in diverse ways to accelerate antibody discovery: 1) Generate ...

While monoclonal antibodies have proven effective, they are constrained by their inability to ... the first bispecific antibody to receive regulatory approval. Other noteworthy examples include ...

Therapeutic monoclonal antibodies have become molecules of choice to treat autoimmune disorders, inflammatory diseases, and cancer. Moreover, bispecific/multispecific antibodies that target more than ...

In this study, two monoclonal antibodies (mAbs) were generated, which could specifically recognize recombinant ... The consistency of these two detection methods was [(48 + 267)/(52 + 273)] = 96.9%.

For example, tocilizumab can be used to manage ... which can be harder for CAR T-cells to reach. Monoclonal antibody (mAb) therapy involves making large amounts of antibodies that recognize ...

A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

We demonstrate here that administration of a CD154-specific monoclonal antibody (hu5C8) allows for renal allotransplantation in outbred, MHC-mismatched rhesus monkeys without acute rejection.